Skip to content
Riskpilot
← Back to search
Sign in
Get full access
VAR2 PHARMACEUTICALS ApS
APS
Active
Advertising protection
CVR 34621942
Nordre Fasanvej 215, 2000
Frederiksberg
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2012 · 14 years old
11 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
VAR2 PHARMACEUTICALS ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (1)
AE
Ali El-Salanti
Management
Management
2012
Former (1)
UA
Ulf Andreas Linderoth Norlin
Management
Management
2018 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (7)
PS
Peter Schröcksnadel
Board of Directors
Board of Directors
2016
PH
Poul Henrik Bredahl Sørensen
Board of Directors
Board of Directors
2016
MD
Mads Daugaard
Chairman
Chairman
2016
JR
Josef Rainer
Board of Directors
Board of Directors
2022
SS
Silviya Stoykova
Board of Directors
Board of Directors
2025
TG
Thor Grundtvig Theander
Board of Directors
Board of Directors
2016
TR
Tanja Rainer
Board of Directors
Board of Directors
2025
Former (1)
MZ
Mai-Britt Zocca
Board of Directors
Board of Directors
2016 – 2019
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
ONCOMAL ApS
Company
90–99.99%
90–99.99%
2013
Københavns Universitet
Company
5–9.99%
5–9.99%
2012
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on VAR2 PHARMACEUTICALS ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network